Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Pat... (harmaceuticals preventive vaccines and d...)

HOME >> MEDICINE >> TECHNOLOGY

Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day

Date:7/8/2008

harmaceuticals, preventive vaccines and diagnostic tools, and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 98,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis Partnerships

Celgene Corporation (Nasdaq: CELG) of Summit, New Jersey granted Novartis Pharma AG an exclusive worldwide (excluding Canada) license covering its intellectual property rights associated with Focalin XR. Pursuant to an agreement between Novartis Pharma AG and Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation markets Focalin XR in the U.S.

Focalin XR was developed with SODAS(R) technology (spheroidal oral drug absorption system), a multiparticulate drug delivery system of Elan Corporation, plc (NYSE: ELN). Focalin XR is being supplied to Novartis under an exclusive worldwide (except Canada) royalty and manufacturing agreement between Elan Corporation, plc, and Novartis Pharma AG.

References

1. Concerta(R) is a registered trademark of ALZA Corporation.

2. The 30 mg dose of Focalin XR is not
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
2. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
3. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:

(Date:5/21/2013)... May 21, 2013 BioRestorative Therapies, Inc. ("BRT" or ... focused on developing stem cell based therapies for various ... , its President and CEO, will be presenting at ... will be held on Thursday, May 30, 2013 at ... Street in New York City. Mr. Weinreb,s presentation will ...

(Date:5/21/2013)... May 21, 2013 AcelRx Pharmaceuticals, Inc. ... pharmaceutical company focused on the development and ... of acute and breakthrough pain, today announced ... Phase 3 study of its investigational sublingual ... System), the primary efficacy endpoint was achieved. ...

(Date:5/21/2013)... RxAlly , a first-of-its-kind alliance of ... publication of a white paper entitled Personalized Pharmacist ... white paper highlights an unprecedented solution for improving ... to avert strains on the health care system. ... range of individually-tailored, pharmacist-provided clinical and consultative services ...

[0] BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference [0] Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain [0] RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care

... 2011 Verilogue, the physician-patient dialogue expert, today ... initiatives, including CareCoach.com, the company,s unique service that ... caregivers and their physicians. The company will be ... e-Patient Connections; the Hyatt at Bellevue; ...

... YORK, Sept. 20, 2011 Reportlinker.com announces ... available in its catalogue: ... Outlook to 2017 ... Africa Cardiovascular Devices Market Outlook to 2017 ...

Verilogue to Present at Upcoming Health IT and Patient-Focused Conferences Middle East and Africa Cardiovascular Devices Market Outlook to 2017

(Date:5/21/2013)... Benefit Express Services, LLC, a leader in ... will be hosting a free Workplace Wellness webinar on ... The presentation will focus on making sure your workplace ... Health Care Reform Requirements. The team will also share ... Express regularly hosts free educational webinars on issues that ...

(Date:5/21/2013)... Three major Ohio universities and four hospitals have ... a new collaborative research program aimed exclusively at finding ... Dimes intends to invest $10 million in the program ... Prematurity Research Center -- Ohio Collaborative is a unique ... the March of Dimes. "This new transdisciplinary, team-based research ...

(Date:5/21/2013)... 2013 EMBO announced today that 52 outstanding researchers ... membership. Forty-three of the researchers reside in Europe and ... nine Associate Members from Canada, China, India, Japan and ... 1600 life scientists. , "Our members are the basis ... Maria Leptin said. "We have been building our network ...

(Date:5/21/2013)... Healthcare Solutions, the parent company ... announced that it was honored to receive the ... Conferred annually, the Innovation Award recognizes a ... cutting edge programs that improves cost and/or quality ... for its clinical and IT solutions that have ...

(Date:5/21/2013)... Two-thirds of patients who have been diagnosed ... that they engage in at least one type of ... findings from the National Health and Wellness Survey ... research will be presented today at the 18th Annual ... Outcomes Research) in New Orleans. , “Cancer ...

Breaking Medicine News(10 mins):Health News:Benefit Express to Host Workplace Wellness Webinar 2 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3 Health News:EMBO announces 52 new members for 2013 2 Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2 Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2 Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3

[0] Benefit Express to Host Workplace Wellness Webinar [0] New multi-million dollar research center aims to solve the mystery of premature birth [0] EMBO announces 52 new members for 2013 [0] Healthcare Solutions Receives Innovation Award From Catamaran [0] Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research

... By Jenifer Goodwin HealthDay Reporter , MONDAY, Sept. ... more likely to suffer socially and emotionally than their normal-weight ... in Australia checked children,s BMI, a measure of height and ... few years later. Parents and teachers filled out questionnaires that ...

... , MONDAY, Sept. 19 (HealthDay News) -- More than ... attack are delayed in getting the emergency artery-opening intervention ... from the fact that only a quarter of American ... that many patients who experience a so-called "ST-segment elevation ...

... D.C. Psychosocial stress could play a role in ... populations, according to study results presented at the Fourth ... held here from Sept. 18-21, 2011. "We found ... reported higher levels of stress than whites, and that ...

... COLUMBIA, Mo. For medications to be effective, they must ... time, as prescribed by healthcare providers. The World Health ... incorrectly, costing the U.S. health care system and consumers ... University of Missouri researchers say medication non-adherence interventions should ...

... effects of cancer treatments. Beth Faiman MSN, ... School of Nursing at Case Western Reserve University, is ... effects for people with blood and bone marrow cancers. ... 1994 at the Cleveland Clinic Taussig Cancer Center with ...

... , MONDAY, Sept. 19 (HealthDay News) -- American youngsters ... than their northern neighbors due to a public health policy ... 4-year olds, according to a Canadian-American research team. The ... the U.S. Advisory Committee on Immunization Practices in 2006. To ...

Cached Medicine News:Health News:Obese Kids May Face Social, Emotional Woes 2 Health News:Obese Kids May Face Social, Emotional Woes 3 Health News:One-Third of Severe Heart Attack Patients Have Treatment Delays 2 Health News:Integrating medication regimens into daily routines can improve adherence 2 Health News:CWRU research examines over-the-counter drug's effect on chemo's side effects 2 Health News:U.S. Flu Shot Policy Shields More Kids Than Canada's Program, Study Finds 2

Obese Kids May Face Social, Emotional Woes One-Third of Severe Heart Attack Patients Have Treatment Delays Association found between stress and breast cancer aggressiveness Integrating medication regimens into daily routines can improve adherence CWRU research examines over-the-counter drug's effect on chemo's side effects U.S. Flu Shot Policy Shields More Kids Than Canada's Program, Study Finds

... Tango exercise BP monitor is designed to ... and diastolic BP along with heart rate. ... for use in treadmill, ergometer and pharmacological ... for use in research environments., ,Tango ...

...

... Tamp is an orthopedic balloon designed to ... Like an angioplasty balloon, it can be ... is inflated with radiopaque contrast medium. The ... volume. The force of balloon growth compacts ...

Medicine Products:

Tango Exercise Stress BP Monitor BD Visispear Eye Sponge BD Visisorb Absorbent Sticks KyphX Xpander Inflatable Bone Tamp